Swiss National Bank
COGT icon

Swiss National Bank’s Cogent Biosciences COGT Stock Holding History

Swiss National Bank’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.37M Hold
165,400
– – ﹤0.01% 1213
2025
Q4 		$5.88M Buy
165,400
+3,200
+2% +$90K ﹤0.01% 1261
2025
Q3 		$2.33M Buy
162,200
+23,100
+17% +$274K ﹤0.01% 1779
2025
Q2 		$999K Hold
139,100
– – ﹤0.01% 2139
2025
Q1 		$833K Buy
139,100
+20,700
+17% +$162K ﹤0.01% 2206
2024
Q4 		$924K Sell
118,400
-3,000
-2% -$29.9K ﹤0.01% 2236
2024
Q3 		$1.31M Sell
121,400
-2,600
-2% -$25.3K ﹤0.01% 2092
2024
Q2 		$1.05M Hold
124,000
– – ﹤0.01% 2153
2024
Q1 		$833K Buy
124,000
+31,400
+34% +$194K ﹤0.01% 2308
2023
Q4 		$544K Sell
92,600
-25,600
-22% -$196K ﹤0.01% 2457
2023
Q3 		$1.15M Hold
118,200
– – ﹤0.01% 2163
2023
Q2 		$1.4M Buy
118,200
+42,800
+57% +$491K ﹤0.01% 2119
2023
Q1 		$814K Sell
75,400
-4,000
-5% -$51.2K ﹤0.01% 2365
2022
Q4 		$918K Buy
+79,400
New +$984K ﹤0.01% 2390

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Swiss National Bank's COGT Position: Q1 2026 in Review

Swiss National Bank held its Cogent Biosciences (COGT) position steady in Q1 2026 at 165,400 shares worth $6.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

Swiss National Bank first reported a position in COGT in Q4 2022 and has held it in 14 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Swiss National Bank held 165,400 shares of Cogent Biosciences worth $6.37M as of Q1 2026.
  • Swiss National Bank left its Cogent Biosciences share count unchanged in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1213 holding.
  • Swiss National Bank first reported a position in Cogent Biosciences in Q4 2022 and has held it in 14 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.